Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Prevalence and founder effect of DRC1 exon 1–4 deletion in Korean patients with primary ciliary dyskinesia

Journal of Human Genetics volume 68, pages 369–374 (2023)Cite this article

Subjects

Abstract

Primary ciliary dyskinesia (PCD) is a genetically heterogeneous disorder affecting ciliary structure and function. PCD exhibiting dynein regulatory complex subunit 1 (DRC1) exon 1–4 deletion has been reported in several Japanese PCD patients; however, no large scale studies have been performed. Here, we aimed to determine the prevalence and founder effect of this variant in the Korean population. Using an in-house copy number variation tool, we screened for DRC1 exon 1–4 deletion in 20 patients with PCD and exome data of 1435 patients in the Seoul National University Hospital repository. In cases of suspected DRC1 deletion, confirmatory gap-PCR was performed. In a PCD cohort, three of 20 (15%) patients were positive for DRC1 exon 1–4 deletion (NM_145038.5(DRC1): c.1‐3952_540 + 1331del27748‐bp) while pathogenic variants were found in CCDC39 (N = 1), DNAAF6 (N = 1), DNAH9 (N = 1). In the 1,435-sample exome data, seven patients (0.49%) were confirmed to have DRC1 exon 1–4 deletion. A chimeric sequence including the junction was searched from the 1000 Genomes Project data repository. One Japanese patient (0.96%) was found to have the same DRC1 exon 1–4 deletion, which was absent in other populations. This study demonstrated that the DRC1 exon 1–4 deletion is a founder mutation based on haplotype analysis. In summary, the prevalence of PCD based on DRC1 exon 1–4 deletion is particularly high in Korean and Japanese populations, which is attributed to the founder effect. Genetic testing for DRC1 exon 1–4 deletion should be considered as an initial screening tool for Korean and Japanese patients with PCD.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Zariwala MA, Knowles MR, Leigh MW. Primary Ciliary Dyskinesia. In: Adam MP, Everman DB, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, et al., editors. GeneReviews((R)). Seattle (WA) 1993.

  2. Bush A, Chodhari R, Collins N, Copeland F, Hall P, Harcourt J, et al. Primary ciliary dyskinesia: current state of the art. Arch Dis Child. 2007;92:1136–40.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Shapiro AJ, Zariwala MA, Ferkol T, Davis SD, Sagel SD, Dell SD, et al. Diagnosis, monitoring, and treatment of primary ciliary dyskinesia: PCD foundation consensus recommendations based on state of the art review. Pediatr Pulmonol. 2016;51:115–32.

    Article  PubMed  Google Scholar 

  4. Niziolek M, Bicka M, Osinka A, Samsel Z, Sekretarska J, Poprzeczko M, et al. PCD genes-from patients to model organisms and back to humans. Int J Mol Sci. 2022;23:1749.

  5. Morimoto K, Hijikata M, Zariwala MA, Nykamp K, Inaba A, Guo TC, et al. Recurring large deletion in DRC1 (CCDC164) identified as causing primary ciliary dyskinesia in two Asian patients. Mol Genet Genom Med. 2019;7:e838.

    Google Scholar 

  6. Keicho N, Hijikata M, Morimoto K, Homma S, Taguchi Y, Azuma A, et al. Primary ciliary dyskinesia caused by a large homozygous deletion including exons 1-4 of DRC1 in Japanese patients with recurrent sinopulmonary infection. Mol Genet Genom Med. 2020;8:e1033.

    Google Scholar 

  7. Takeuchi K, Xu Y, Kitano M, Chiyonobu K, Abo M, Ikegami K, et al. Copy number variation in DRC1 is the major cause of primary ciliary dyskinesia in the Japanese population. Mol Genet Genom Med. 2020;8:e1137.

    CAS  Google Scholar 

  8. Kim YG, Sung H, Shin HS, Kim MJ, Lee JS, Park SS, et al. Intronic LINE-1 insertion in SLCO1B3 as a highly prevalent cause of rotor syndrome in East Asian population. J Hum Genet. 2022;67:71–7.

    Article  CAS  PubMed  Google Scholar 

  9. Kobayashi K, Nakahori Y, Miyake M, Matsumura K, Kondo-Iida E, Nomura Y, et al. An ancient retrotransposal insertion causes Fukuyama-type congenital muscular dystrophy. Nature. 1998;394:388–92.

    Article  CAS  PubMed  Google Scholar 

  10. Yau WY, Vandrovcova J, Sullivan R, Chen Z, Zecchinelli A, Cilia R, et al. Low prevalence of NOTCH2NLC GGC repeat expansion in white patients with movement disorders. Mov Disord. 2021;36:251–5.

    Article  CAS  PubMed  Google Scholar 

  11. Kusters DM, Huijgen R, Defesche JC, Vissers MN, Kindt I, Hutten BA, et al. Founder mutations in the Netherlands: geographical distribution of the most prevalent mutations in the low-density lipoprotein receptor and apolipoprotein B genes. Neth Heart J. 2011;19:175–82.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Saha B, Lessel D, Nampoothiri S, Rao AS, Hisama FM, Peter D, et al. Ethnic-specific WRN mutations in South Asian Werner syndrome patients: potential founder effect in patients with Indian or Pakistani Ancestry. Mol Genet Genom Med. 2013;1:7–14.

    Article  CAS  Google Scholar 

  13. ElBiad O, Laraqui A, El Boukhrissi F, Mounjid C, Lamsisi M, Bajjou T, et al. Prevalence of specific and recurrent/founder pathogenic variants in BRCA genes in breast and ovarian cancer in North Africa. BMC Cancer. 2022;22:208.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Zlotogora J. High frequencies of human genetic diseases: founder effect with genetic drift or selection? Am J Med Genet. 1994;49:10–3.

    Article  CAS  PubMed  Google Scholar 

  15. Kim MJ, Lee S, Yun H, Cho SI, Kim B, Lee JS, et al. Consistent count region-copy number variation (CCR-CNV): an expandable and robust tool for clinical diagnosis of copy number variation at the exon level using next-generation sequencing data. Genet Med. 2022;24:663–72.

    Article  CAS  PubMed  Google Scholar 

  16. Stephens M, Smith NJ, Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet. 2001;68:978–89.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Stephens M, Donnelly P. A comparison of bayesian methods for haplotype reconstruction from population genotype data. Am J Hum Genet. 2003;73:1162–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Stephens M, Scheet P. Accounting for decay of linkage disequilibrium in haplotype inference and missing-data imputation. Am J Hum Genet. 2005;76:449–62.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Fassad MR, Shoman WI, Morsy H, Patel MP, Radwan N, Jenkins L, et al. Clinical and genetic spectrum in 33 Egyptian families with suspected primary ciliary dyskinesia. Clin Genet. 2020;97:509–15.

    Article  CAS  PubMed  Google Scholar 

  20. Paff T, Kooi IE, Moutaouakil Y, Riesebos E, Sistermans EA, Daniels H, et al. Diagnostic yield of a targeted gene panel in primary ciliary dyskinesia patients. Hum Mutat. 2018;39:653–65.

    Article  CAS  PubMed  Google Scholar 

  21. Wirschell M, Olbrich H, Werner C, Tritschler D, Bower R, Sale WS, et al. The nexin-dynein regulatory complex subunit DRC1 is essential for motile cilia function in algae and humans. Nat Genet. 2013;45:262–8.

    Article  CAS  PubMed  Google Scholar 

  22. Lei C, Yang D, Wang R, Ding S, Wang L, Guo T, et al. DRC1 deficiency caused primary ciliary dyskinesia and MMAF in a Chinese patient. J Hum Genet. 2022;67:197–201.

    Article  CAS  PubMed  Google Scholar 

Download references

Funding

This research was supported by a fund (2020-ER6904-01) by Research of Korea Centers for Disease Control and Prevention. JM was supported by the Seoul National University Hospital Research Fund (0320210170).

Author information

Author notes

  1. These authors contributed equally: Man Jin Kim, Sheehyun Kim.

Authors and Affiliations

  1. Department of Genomic Medicine, Seoul National University Hospital, Seoul, Korea

    Man Jin Kim, Sheehyun Kim, Seungbok Lee, Jihoon G. Yoon, Jong Hee Chae & Jangsup Moon

  2. Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea

    Sheehyun Kim

  3. Department of Laboratory Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea

    Seung Won Chae, Boram Kim, Jee-Soo Lee & Moon-Woo Seong

  4. Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea

    Seung Won Chae

  5. Department of Pediatrics, Seoul National University Children’s Hospital, Seoul National University College of Medicine, Seoul, Korea

    Seungbok Lee & Jong Hee Chae

  6. Department of Neurology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea

    Jangsup Moon

Authors
  1. Man Jin Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sheehyun Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Seung Won Chae
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Seungbok Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Jihoon G. Yoon
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Boram Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Jee-Soo Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Jong Hee Chae
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Moon-Woo Seong
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Jangsup Moon
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Moon-Woo Seong or Jangsup Moon.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kim, M.J., Kim, S., Chae, S.W. et al. Prevalence and founder effect of DRC1 exon 1–4 deletion in Korean patients with primary ciliary dyskinesia. J Hum Genet 68, 369–374 (2023). https://doi.org/10.1038/s10038-023-01122-8

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s10038-023-01122-8

This article is cited by

Search

Advanced search

Quick links